Towards patient welfare-centred pharmaceutical patents—a sustainable perspective

Irene Lorenzo-Rego

Journal of Intellectual Property Law and Practice, 2024, vol. 19, issue 3, 250-255

Abstract: Encouraging innovation by rewarding pharmaceutical patent holders is a key to societal progress, given mandatory disclosure and adequate reimbursement. Following debate on fair prices from a competition law perspective, the recent Health Trade Assessment Regulation provides Member States with a harmonized tool to help them set prices in a more sustainable way.This article discusses the extent to which the Regulation will provide comprehensive access to healthcare as an expression of patient welfare, framing the debate in terms of sustainability.

Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1093/jiplp/jpad115 (application/pdf)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oup:jiplap:v:19:y:2024:i:3:p:250-255.

Access Statistics for this article

Journal of Intellectual Property Law and Practice is currently edited by Eleonora Rosati, Stefano Barazza and Marius Schneider

More articles in Journal of Intellectual Property Law and Practice from Oxford University Press
Bibliographic data for series maintained by Oxford University Press ().